(Q48168541)

9 February 2018

editorial

0 references

review article

1 reference

title

5-HT and the brain-gut axis: opportunities for pharmacologic intervention (English)

1 reference

9 February 2018

author

Michael D. Crowell

series ordinal

1

1 reference

9 February 2018

author name string

Sarah B Wessinger

series ordinal

2

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

9 February 2018

Expert Opinion on Investigational Drugs

published in

1 reference

9 February 2018

volume

16

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

761-765

1 reference

9 February 2018

Review article: an integrated approach to the irritable bowel syndrome

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Functional bowel disorders and functional abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Clinical economics review: irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

The irritable bowel syndrome: a paroxysmal motor disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Sleep and gastric function in irritable bowel syndrome: derailing the brain-gut axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Evidence for autonomic nervous system imbalance in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Hyperventilation, central autonomic control, and colonic tone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

The enteric nervous system: a second brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Changes in pyloric resistance induced by erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.6.761

10.1517/13543784.16.6.761

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018